Rising costs, staff shortages and a royal reception: 2022 in review
National Pharmacy Association (NPA) boss Mark Lyonette provides his reflections on 2022 and his hopes for 2023 in the first of our C+Dmas series
To say it’s been a difficult year for community pharmacy would be to put it very mildly indeed.
Our members are feeling overworked, under-appreciated and underfunded. Spiralling medicines costs are putting pressure on cash-flow and staff shortages have become endemic.
Rises in operational costs are far outstripping NHS funding.
An NPA-commissioned report this autumn highlighted the likely consequences of all this for the NHS and for patients.
Read more: Taking the pressure off: What do pharmacists want their future to look like?
This month’s situation with disrupted antibiotic supplies means the year is ending with even more stress for everyone! The situation is publicly exposing the fragility of the medicines supply chain and the absurdity of dispensing at a loss.Read more: Not fair: Public backs calls for increased pharmacy funding as pressures intensify
Mark Lyonette is chief executive of the NPA